More recently, a large-scale sequencing analysis of datasets of 15 cancer types from The Cancer Genome Atlas (TCGA) confirmed these data, showing an inverse correlation between the DNA methylation status of the IGF2BP3 promoter and IGF2BP3 mRNA expression (Panebianco et al., 2017). This evidence concerns the gene IGF2BP3 and cancer.